Stocks › EYPT
EyePoint, Inc.
EYPT·Nasdaq·
United States·USD
United States·USD$0.44
-2.55 (-85.28%)
Close · Oct 19, 2026 · Close Prices from Tiingo.com
EYPT
EyePoint, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
EYPTS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of EYPT by members of U.S. Congress · 0 on record
No congressional trades in EYPT on record.
Whale Activity
Position changes in EYPT reported for 2026-06-30 by 11 tracked institutional filers
- Increased7
- New1
- Held0
- Decreased0
- Closed1
- No prior filing2
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 7.5M | $106.7M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6M | $51.9M | increased |
| CITADEL ADVISORS LLC | 2.0M | $28.3M | increased |
| TWO SIGMA INVESTMENTS, LP | 1.2M | $16.9M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 971.0K | $13.9M | increased |
| Principia Wealth Advisory, LLC | 649.9K | $9.3M | increased |
| MILLENNIUM MANAGEMENT LLC | 500.1K | $7.2M | increased |
| MYDA Advisors LLC | 250.0K | $3.6M | — |
| SILVERBACK ASSET MANAGEMENT LLC | 50.0K | $715K | — |
| Point72 Asset Management, L.P. | 48.6K | $695K | new |
| Renaissance Technologies | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by EYPT insiders, by quarter · Form 4
Recent Insider Transactions
371 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Elston GeorgeChief Financial Officer | Gift | +65.0K | $0.00 | $0 | Aug 20, 2026 | Form 4 ↗ |
| Elston GeorgeChief Financial Officer | Gift | −65.0K | $0.00 | $0 | Aug 20, 2026 | Form 4 ↗ |
| Elston GeorgeChief Financial Officer | Other | +5,000 | $0.00 | $0 | Aug 20, 2026 | Form 4 ↗ |
| Elston GeorgeChief Financial Officer | Other | −5,000 | $0.00 | $0 | Aug 20, 2026 | Form 4 ↗ |
| Zaderej Karen L.Director | Purchase | +10.6K | $4.93 | $52K | Aug 18, 2026 | Form 4 ↗ |
| Duker Jay S.President and CEO · Director | Tax withholding | −8,059 | $14.72 | $119K | Jul 10, 2026 | Form 4 ↗ |
| Duker Jay S.President and CEO · Director | Option exercise | +16.7K | $0.00 | $0 | Jul 10, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Sale | −2,438 | $15.02 | $37K | Jun 30, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Sale | −2,437 | $15.00 | $37K | Jun 30, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Option exercise | +2,438 | $8.26 | $20K | Jun 30, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Option exercise | +2,437 | $8.26 | $20K | Jun 30, 2026 | Form 4 ↗ |
| Elston GeorgeChief Financial Officer | Tax withholding | −3,627 | $12.93 | $47K | May 25, 2026 | Form 4 ↗ |
| Elston GeorgeChief Financial Officer | Option exercise | +7,500 | $0.00 | $0 | May 25, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Sale | −2,437 | $15.00 | $37K | Apr 17, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Option exercise | +2,437 | $8.26 | $20K | Apr 17, 2026 | Form 4 ↗ |
| Duker Jay S.President and CEO · Director | Other | +76.8K | $13.11 | $1.0M | Mar 23, 2026 | Form 4 ↗ |
| Duker Jay S.President and CEO · Director | Other | −76.8K | $13.11 | $1.0M | Mar 23, 2026 | Form 4 ↗ |
| Duker Jay S.President and CEO · Director | Purchase | +1,500 | $13.15 | $20K | Mar 16, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Sale | −2,438 | $17.87 | $44K | Mar 4, 2026 | Form 4 ↗ |
| Ribeiro RamiroChief Medical Officer | Option exercise | +2,438 | $8.26 | $20K | Mar 4, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding EYPT · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.6M | $37.8M | 0.00% | Jun 30, 2026 |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 2.8M | $34.0M | 0.69% | Jul 31, 2026 |
| iShares Russell 2000 ETF iShares Trust | 2.0M | $28.9M | 0.03% | Jun 30, 2026 |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 2.0M | $24.3M | 0.85% | Jul 31, 2026 |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 1.2M | $17.8M | 1.00% | Jun 30, 2026 |
| abrdn Healthcare Investors | 1.2M | $17.5M | 1.28% | Jun 30, 2026 |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 1.1M | $13.8M | 1.19% | Jul 31, 2026 |
| Franklin Small Cap Growth Fund Franklin Strategic Series | 1.1M | $13.3M | 0.54% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 895.9K | $12.8M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 846.5K | $10.4M | 0.03% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list EYPT's shares (CUSIP 30233G209), each fund at its latest report since Mar 20, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- J. Christopher DonahueSCHEDULE 13G/A · passive (13G) · 6.9M shares8.0%
Oct 7, 2026 · ↗ - Ann C. DonahueSCHEDULE 13G/A · passive (13G) · 6.9M shares8.0%
Oct 7, 2026 · ↗ - Thomas R. DonahueSCHEDULE 13G/A · passive (13G) · 6.9M shares8.0%
Oct 7, 2026 · ↗ - Voting Shares Irrevocable TrustSCHEDULE 13G/A · passive (13G) · 6.9M shares8.0%
Oct 7, 2026 · ↗ - Federated Hermes, Inc.SCHEDULE 13G/A · passive (13G) · 6.9M shares8.0%
Oct 7, 2026 · ↗ - JANUS HENDERSON GROUP Ltd.SCHEDULE 13G · passive (13G) · 9.4M shares10.9%
Sep 8, 2026 · ↗ - Bihua ChenSCHEDULE 13G/A · passive (13G) · 7.0M shares8.3%
Aug 14, 2026 · ↗ - Cormorant Asset Management, LPSCHEDULE 13G/A · passive (13G) · 7.0M shares8.3%
Aug 14, 2026 · ↗ - Phillip GrossSCHEDULE 13G · passive (13G) · 4.8M shares5.7%
Aug 12, 2026 · ↗ - Robert AtchinsonSCHEDULE 13G · passive (13G) · 4.8M shares5.7%
Aug 12, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming EyePoint, Inc. as client
No lobbying filings found naming EyePoint, Inc. as the client.
Government Contracts
Federal awards to EyePoint, Inc. · USAspending
No federal contract awards found for EyePoint, Inc..
U.S. Patents
Recent USPTO applications naming EyePoint, Inc.
No USPTO patent applications found for EyePoint, Inc..
Annual Financials
From EYPT's 10-K filings · XBRL
No annual XBRL figures on record for EYPT. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 1-for-10Reverse splitDec 9, 2020
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 2.05, 8.01, 9.01Results of operations · Exit or disposal costs · Other eventsOct 19, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsOct 19, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsSep 10, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsAug 17, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 5, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJul 30, 2026
EDGAR ↗ - 8-K · Items 1.01, 9.01Material agreementJul 17, 2026
EDGAR ↗ - 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteJun 22, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsMay 14, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 6, 2026
EDGAR ↗
About EyePoint, Inc.
From SEC EDGAR company records
Industry (SIC 3826)Laboratory Analytical Instruments
SectorTechnology
HeadquartersWATERTOWN, MA
IncorporatedDE
SEC CIK0001314102 ↗
Former namesEyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD